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Duijnisveld et al. have published an interesting study
on the regenerative potential of muscle satellite cells
in chronic inflammation in this journal [1]. They
showed that muscle stem cell populations obtained
from M. vastus medialis of patients with rheumatoid
arthritis (RA) and osteoarthritis (OA) exhibited simi-
lar myogenic purity, viability, growth speed, differenti-
ation, and maximum proliferative capacity. Based on
these findings in vitro, the authors hypothesized that
circulating inflammatory factors in RA negatively in-
fluence the regenerative potential of satellite cells and
muscle strength in vivo. We aimed to verify whether
these results obtained from vastus medialis muscles
also apply to a muscle typically involved in the dis-
ease process of RA, namely M. interosseus dorsalis
manus 1.
For this purpose, we obtained intraoperative muscle
biopsies from the M. interosseus dorsalis manus 1 of
five RA (57.2 ± 11.1 years old) and four OA (60.7 ±
12.1 years old) patients and tested whether satellite cell
numbers, myofiber sizes, and proportions were differ-
ent between RA and OA patients. There was no differ-
ence in muscle fiber type distribution between RA and
OA patients (Table 1). Myofiber cross-sectional area
(CSA), myonuclear domains, the number of Pax7+ cells,
and the number of proinflammatory macrophages
(CD68+) were not different between RA and OA pa-
tients. There was a tendency for increased myonuclear
number in myosin heavy chain (MyHC)-1 fibers in RA
patients compared with OA patients, while there was
no difference in myonuclear number in MyHC-2 fibers
between the groups. MyHC-2 fiber CSAs in M. interos-
seus dorsalis manus 1 were significantly larger than
MyHC-1 CSAs in RA and OA patients (Table 1).
Our results point towards similar muscle character-
istics between RA and OA patients in the highly
affected M. interosseus dorsalis manus 1. Moreover,
we found that most values for RA patients seemed to
be higher when compared with OA in this prelimin-
ary dataset. Notably, there was a tendency for in-
creased myonuclear number in MyHC-1 fibers in RA
patients. Our results from a severely affected skeletal
area are in line with previous studies investigating
other skeletal sites. In M. vastus medialis, MyHC-2
CSAs were significantly larger than MyHC-1 CSAs in
RA patients [2] and no significant differences in satel-
lite cell numbers between RA and OA patients were
present [3]. Based on our results from a small patient
sample, the hypothesis that chronic systematic inflam-
mation negatively influences the regenerative potential
of satellite cells and myonuclei number cannot be
confirmed, but it warrants further investigation.
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Table 1 M. interosseus dorsalis manus 1 characteristics in
rheumatoid arthritis and osteoarthritis patients
Rheumatoid arthritis (n = 5) Osteoarthritis (n = 4)
MyHC-1 (%) 74.4 ± 15.6 73.3 ± 19.8
MyHC-2A (%) 23.8 ± 13.6 23.6 ± 20.8
MyHC-2X (%) 1.8 ± 2.3 3.1 ± 3.2
CSA MyHC-1 (μm2) 2534 ± 714 1906 ± 773
CSA MyHC-2 (μm2) 4263 ± 1752* 3177 ± 1201*
MN MyHC-1 2.31 ± 0.47 1.95 ± 0.31
MN MyHC-2 3.06 ± 0.75 2.06 ± 0.66#
MND MyHC-1 (μm2) 1240 ± 389 1093 ± 323
MND MyHC-2 (μm2) 1523 ± 382 1354 ± 550
Pax7+ MyHC-1 0.038 ± 0.025 0.020 ± 0.008
Pax7+ MyHC-2 0.049 ± 0.075 0.028 ± 0.025
CD86+ MyHC-1 0.036 ± 0.019 0.034 ± 0.020
CD86+ MyHC-2 0.055 ± 0.025 0.038 ± 0.026
Data are shown as mean ± SD
*P < 0.05, significantly different between MyHC-1 and MyHC-2 fibers within
group; #P < 0.1, tendency for a between-group difference
CSA cross-sectional area, MN myonuclear number, MND myonuclear domain,
MyHC myosin heavy chain
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